Eli Lilly's Q2 2024 Financial Report: Key Highlights
Thursday, 8 August 2024, 13:01
Eli Lilly's Impressive Financial Performance
Eli Lilly and Company (NYSE: LLY) reported a remarkable increase in both revenues and profits for the second quarter of 2024. The financial highlights include:
- 36% Year-on-Year Revenue Growth: Total revenue reached $11.3 billion.
- Key Product Drivers: Sales from Mounjaro, Zepbound, and Verzenio were significant contributors to this growth.
- Updated Guidance: The company raised its full-year financial guidance.
Conclusion
The strong performance and updated guidance from Eli Lilly indicate a promising outlook for the company in the pharmaceutical market.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.